Lily ZhangSenior Partner, VGC at CDH Investments
Lily Zhang joined CDH VGC in 2015 with primary focus on healthcare, including medical device and pharmaceutical sector. Prior to joining CDH, Lily was Business Development and Market Intelligence Director at GSK China where she was responsible for M&A, licensing, and divesture deals in the healthcare sector. Prior to that, she worked at Johnson & Johnson, responsible for Asia Pacific and China Business Development, including M&A and in-licensing deals. Lily received her MBA from Wharton Business School.